« Back to Record
Citation APA

Zwingli, G., Putananickal, N., Schmidt, S., Nagy, S., Rubino–Nacht, D., Schaedelin, S., Amthor, H., Childs, A. –., Deconinck, N., Horrocks, I., Houwen–van Opstal, S., Laugel, V., Lopez Lobato, M., Nascimento Osorio, A., Schara–Schmidt, U., Spinty, S., von Moers, A., Lawrence, F., Hafner, P., Dorchies, O. O., Fischer, D., & Henzi, B. C. (2026). Safety and efficacy of tamoxifen in patients with duchenne muscular dystrophy: open label extension of TAMDMD trial. Neuromuscular disorders, 61, 106366. doi:10.1016/j.nmd.2026.106366


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/407538

Zwingli, G., Putananickal, N., Schmidt, S., Nagy, S., Rubino–Nacht, D., Schaedelin, S., Amthor, H., Childs, A. –., Deconinck, N., Horrocks, I., Houwen–van Opstal, S., Laugel, V., Lopez Lobato, M., Nascimento Osorio, A., Schara–Schmidt, U., Spinty, S., von Moers, A., Lawrence, F., Hafner, P., Dorchies, O. O., Fischer, D., & Henzi, B. C. (2026). Safety and efficacy of tamoxifen in patients with duchenne muscular dystrophy: open label extension of TAMDMD trial. Neuromuscular disorders, 61, 106366. doi:10.1016/j.nmd.2026.106366